C-CAMP collaborates with Swiss organisation to tackle resistant bacterial infections
The letter of intent being signed by Taslimarif Saiyed, CEO-Director of C-CAMP, François Franceschi, Head of Asset Evaluation and Development at GARDP, and Subasree Srinivasan, GARDP Medical Director. The Centre for Cellular and Molecular Platforms (C-CAMP) has joined hands with a Swiss not-for-profit organization, Global Antibiotic Research and Development Partnership (GARDP), to tackle the global … Read more